Table 2: Gene frequencies of HLA-B alleles in patients with ALL compared with umbilical cord blood samples, as a control group.

B* allelePatients Controls P OR95% CI
g. f. g. f.

07160.0375600.0410NS
08100.0234400.0273NS
1340.0093140.0095NS
14150.0352550.0376NS
15350.08211350.0923NS
18110.0258420.0287NS
2780.0187190.0129NS
35730.17132960.2024NS
38100.0234150.0102NS
39520.12202540.17370.0040.610.42–0.87
40620.14551440.09840.0031.671.16–2.40
4190.0211130.0088NS
4210.002390.0061NS
44250.0586750.0512NS
45100.0234180.0123NS
48150.0352570.0389NS
49130.0305290.0198NS
51230.0539860.0588NS
52130.0305400.0273NS
5350.0117170.0116NS
5530.007020.0013NS
5610.002320.0013NS
5730.0070150.0102NS
5840.009360.0041NS

ALL: acute lymphoid leukemia; g. f.: gene frequency; OR: odds ratio; CI: confidence interval; NS: not significant.